Description

AV Therapeutics, Inc . (AVT) is engaged in the business of developing cancer therapeutics and immunotherapeutic vaccines. These vaccines together can be used with prevalent treatment modalities such as chemotherapy and radiation to treat active disease and to prevent metastases and recurrence. The Companys chemotherapeutic drug called Capridine is in a pre-clinical stage to have specific activity against prostate and colon cancer. This drug is engaged in prostate cancer where limited chemotherapy is available. AVT licensed drugs have been tested by the NCI National Cancer Institute (NCI) and found to be effective against a number of tumor systems. These included prostate cancer, colon cancer and others. These drugs inhibit the Deoxyribo-nucleic acid (DNA) in the cancer cells and therefore lead to the death of these cancer cells.